Industry Slams Brazilian Plans To Change Importation Rules
Move Could Disadvantage Local Manufacturers And Risk Patient Safety
Industry representatives are at odds with the Brazilian medicines regulator and health ministry over plans to change the regulations on importing unregistered medicines in exceptional circumstances.
You may also be interested in...
Industry access to real world data for regulatory and market access purposes in Asia Pacific compares poorly with the US.
Draft guidelines due out for consultation this week in Italy are expected to shed more light on what companies will have to reveal during pricing and reimbursement negotiations.
Germany is for the first time to adopt national guidelines on prescribing biologics and biosimilars in a move towards increasing biosimilar uptake.